SCHEMBL3246965

SCHEMBL3246965

COC(=O)c1[nH]c2ccccc2c1C(N)=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 2/20 0.60
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
TUBB4A P04350 2/20 0.59
TUBB P07437 2/20 0.59
TUBA3C P0DPH7 2/20 0.59
TUBA1B P68363 2/20 0.59
TUBA4A P68366 2/20 0.59
TUBB4B P68371 2/20 0.59
TUBB3 Q13509 2/20 0.59
TUBB2A Q13885 2/20 0.59
TUBB8 Q3ZCM7 2/20 0.59
TUBA3E Q6PEY2 2/20 0.59
TUBA1A Q71U36 2/20 0.59
TUBA1C Q9BQE3 2/20 0.59
TUBB6 Q9BUF5 2/20 0.59
TUBB2B Q9BVA1 2/20 0.59
TUBB1 Q9H4B7 2/20 0.59
KDM4E B2RXH2 4/20 0.55
ALDH1A1 P00352 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3275502 0.89 NR4A2 (0.71) NR4A2MEN1KMT2ATUBB4ATUBB
SCHEMBL3275504 0.86 MEN1 (0.65) NR4A2MEN1KMT2ATUBB4ATUBB
SCHEMBL18824256 0.83 MAP2 (0.62) NR4A2MEN1KMT2AKDM4EALDH1A1
SCHEMBL31305695 0.82 NR4A2 (0.57) NR4A2MEN1KMT2ATUBB4ATUBB
SCHEMBL5220303 0.81 KDM4E (0.66) NR4A2MEN1KMT2ATUBB4ATUBB
SCHEMBL31019418 0.81 KDM4E (0.66) NR4A2MEN1KMT2ATUBB4ATUBB
SCHEMBL721793 0.80 MAP2 (0.58) MEN1KMT2AKDM4EALDH1A1HSD17B10
SCHEMBL3262790 0.80 KDM4E (0.53) MEN1KMT2ATUBB4ATUBBTUBA3C
SCHEMBL3253095 0.80 KDM4E (0.56) NR4A2MEN1KMT2ATUBB4ATUBB
SCHEMBL8528482 0.79 NR4A2 (0.67) NR4A2MEN1KMT2ATUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651639-B1 BENZOFURAN DERIVATIVES AND THEIR USE IN THE TREATMENT OF MICROBIAL INFECTIONS ARPIDA AG (CH) 2010-05-26 EP disclosed
US-7524854-B2 Benzofuran derivatives and their use in the treatment of microbial infections ARPIDA AG (CH) 2009-04-28 US disclosed
US-20060154943-A1 Benzofuran derivatives and their use in the treatment of microbial infections ARPIDA AG (CH) 2006-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060154943-A1 Benzofuran derivatives and their use in the treatment of microbial infections DCXR, NLRP3, NISCH NR4A2 2263/4885MEN1 4151/4885KMT2A 3351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.